DELL vs DHR: Which Is the Better Buy?
Side-by-side comparison of Dell Technologies Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Dell Technologies Inc. · Technology
$410.00
-12.0% upside to fair value
Grade D
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DELL trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DELL |
DHR |
| Current Price |
$410.00 |
$177.17 |
| Fair Value Estimate |
$360.77 |
$192.90 |
| Upside to Fair Value |
-12.0%
|
+8.9%
|
| Market Cap |
$272.3B |
$125.4B |
| Forward P/E |
32.0x
|
34.1x
|
| EV / EBITDA |
22.1x
|
20.8x
|
| Price / Sales |
2.0x
|
5.1x
|
| Price / FCF |
28.8x
|
23.7x
|
| Revenue Growth YoY |
+87.5%
|
+3.7%
|
| Gross Margin |
19.2%
|
60.7%
|
| Operating Margin |
8.0%
|
21.0%
|
| Return on Equity |
-363.2%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.47%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Dell Technologies Inc. is a leading global provider of computer hardware and infrastructure solutions, with a strong competitive position in commercial PCs and x86 servers where it holds a top 1-2 market share around the low to mid-20% range. The company benefits from founder Michael Dell's long tenure and high insider ownership, which supports disciplined capital allocation including buybacks, d…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
DELL |
DHR |
| Zone Low |
$270.58 |
$144.68 |
| Zone High |
$306.65 |
$163.97 |
| In Buy Zone? |
No
|
No
|